Researchers say new research findings might point to a major opportunity to act sooner to prevent rheumatoid arthritis.

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

Julianna LeMieux and Uduak Thomas discuss their time at the ASHG meeting in Denver and some of the trends that they are ...

Researchers say study offers proof-of-concept that targeting how T cells interact with metabolites in their environment can ...

New research demonstrates how a chemical produced by a caterpillar fungus shows promise as a possible cancer treatment by ...

PacBio launches the Vega System: a new sequencing platform that brings the company's HiFi sequencing technology to the ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

In this GEN webinar, our speakers will present important considerations for quality control testing for biosafety and product ...

ASHG 2024 professional awardees include two awardees in the lifetime achievement category and one awardee each in the ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

The combination of cell-free bioprocessing technology, microbial transformation, and AI offers an efficient pathway for ...